<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01619124</url>
  </required_header>
  <id_info>
    <org_study_id>DKS 2011.11</org_study_id>
    <nct_id>NCT01619124</nct_id>
  </id_info>
  <brief_title>Osteonecroses in Pediatric Patients With ALL</brief_title>
  <acronym>OPAL</acronym>
  <official_title>Part I: Incidence, Clinical Course and Significance of MRI for Early Diagnosis of Osteonecrosis in Children and Adolescents With Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL) Part II: Susceptibility for Aseptic Osteonecroses in Children and Adolescents With Chemotherapy for ALL or LBL</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Klinik für Kinder-Onkologie, -Hämatologie und Klinische Immu</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Heinrich-Heine University, Duesseldorf</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Nowadays approximately 80% of children and adolescents with acute lymphoblastic leukaemia
      (ALL) or lymphoblastic lymphoma (LBL) can be cured and become long-term survivors. Avascular
      osteonecroses (ON) appear as serious side-effect of antileukaemic treatment. Frequently ON
      are first diagnosed at higher and than irreversible stages (ARCO III, IV). At these advanced
      stages curative treatment options are not available. Hence ON are associated with
      considerable morbidity concerning pain and immobility and go along with long-term impairment
      of quality of life. Therefore early diagnosis of ON in the follow-up of children and young
      adults with ALL or LBL is a pressing object.

      Within the prospective multicentric observational OPAL-trial patients at risk (aged 10 years
      or older) treated according to the clinical trials ALL-BFM(Berlin-Frankfurt-Muenster Study
      Group), COALL or NHL (Non Hodgkin Lymphoma)-BFM in Germany should be examined with regard to
      the development of ON. By using a treatment associated, risk orientated assessment and
      examination incidence, symptoms and the clinical course of ON are investigated. The validity
      of MRI screening in the early diagnosis of ON in children and young adults is analysed.

      Systematical investigation of patients under antileukaemic treatment is intended to
      contribute to risk adapted diagnostic strategies and to serve as data base for the subsequent
      evaluation of preventive and interventional approaches for the treatment of ON. Long-term
      objective is the reduction of ON-associated morbidity.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Anticipated">March 2020</completion_date>
  <primary_completion_date type="Anticipated">March 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>occurence of early ON stages</measure>
    <time_frame>6 years</time_frame>
    <description>Calculation of the rate of by MRI detectable (still) asymptomatic patients with early ON stages (I and II) within the patients who develop symptomatic ON in the further course</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>ON incidence</measure>
    <time_frame>6 years</time_frame>
    <description>Prospective evaluation of incidence of asymptomatic and symptomatic ON in children and adolescents with ALL or LBL</description>
  </secondary_outcome>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Osteonecrosis</condition>
  <condition>Acute Lymphoblastic Leukaemia</condition>
  <condition>Lymphoblastic Lymphoma</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      whole blood, serum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Pediatric patients with acute lymphoblastic leukemia or lymphoblastic lymphoma, aged &gt;= 10
        and &lt; 18 years
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  diagnosis of ALL or LBL

          -  age at diagnosis of ALL or LBL ≥ 10 and &lt; 18 years

          -  study patient of AIEOP( Associazione Italiana Ematologia ed Oncologia Pediatrica)-BFM,
             COALL or NHL-BFM in Germany

          -  treatment in a hospital participating in OPAL

          -  written informed consent

        Exclusion Criteria:

          -  relapse of ALL or LBL

          -  every non evidence based treatment (pharmacological, orthopaedic-conservative,
             orthopaedic operative) aiming at the prevention of ON during study participation

          -  pacemaker, other MRI prohibited devices

          -  metal implants in the field of view, other MRI prohibited implants

          -  pregnancy

          -  claustrophobia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michaela Kuhlen, Dr. med.</last_name>
    <role>Study Chair</role>
    <affiliation>Heinrich-Heine University, Duesseldorf</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michaela Kuhlen, Dr. med.</last_name>
    <phone>+49 211 81 17687</phone>
    <email>Michaela.Kuhlen@med.uni-duesseldorf.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Paediatric and Adolescend Medicine, University Aachen</name>
      <address>
        <city>Aachen</city>
        <zip>52074</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rolf Mertens, Prof. Dr.</last_name>
      <phone>+49-(0)241-8089902</phone>
    </contact>
    <investigator>
      <last_name>Rolf Mertens, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Pediatrics, Haematology and Oncology, University Bonn</name>
      <address>
        <city>Bonn</city>
        <zip>53113</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dagmar Dilloo, Prof. Dr.</last_name>
      <phone>+49-(0)2873-3254</phone>
    </contact>
    <investigator>
      <last_name>Carola Weber, Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department for Children and Adolescent Helth Chemnitz gGmbH</name>
      <address>
        <city>Chemnitz</city>
        <zip>09009</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Scholbach, Prof. Dr.</last_name>
      <phone>+49-(0)371-33324124</phone>
    </contact>
    <investigator>
      <last_name>André Hofmann, Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinic of Pediatric and Adolescent Medicine, Vestische Caritas Clinic Datteln</name>
      <address>
        <city>Datteln</city>
        <zip>45711</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Wiesel, Dr.</last_name>
      <phone>+49(0)2363-975-392</phone>
    </contact>
    <investigator>
      <last_name>Thomas Wiesel, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Division of Pediatric Hematology and Oncology, University Children´s Hospital</name>
      <address>
        <city>Dresden</city>
        <zip>01307</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Meinolf Suttorp, Prof. Dr.</last_name>
      <phone>+49-(0)351-4583522</phone>
    </contact>
    <investigator>
      <last_name>Meinolf Suttorp, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinic of Pediatric Oncology, Hematology and Clinical Immunology, Center for Child and Adolescent Health, Heinrich Heine University</name>
      <address>
        <city>Duesseldorf</city>
        <zip>40225</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michaela Kuhlen, Dr. med.</last_name>
      <phone>+49(0)211-811-7687</phone>
      <email>Michaela.Kuhlen@med.uni-duesseldorf.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinic of Pediatrics and Adolescent , Pediatric Hematology and Oncology</name>
      <address>
        <city>Erlangen</city>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>M. Metzler, Dr.</last_name>
      <phone>+49-(0)9131-8533117</phone>
    </contact>
    <investigator>
      <last_name>M. Metzler, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Pediatric-Oncology/-Hematology and clin. Immunology, University Medicine Essen</name>
      <address>
        <city>Essen</city>
        <zip>45122</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>M. Schündeln, Dr.</last_name>
      <phone>+49-(0)201-723-84282</phone>
    </contact>
    <investigator>
      <last_name>M. Schündeln, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Pediatric Hematology, Oncology and Hemostaseology, Goethe-University, University Children's Hospital</name>
      <address>
        <city>Frankfurt/Main</city>
        <zip>60590</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Klingebiel, Prof. Dr.</last_name>
      <phone>+49-(0)69-6301-5094</phone>
    </contact>
    <investigator>
      <last_name>Thomas Klingebiel, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pediatric Hematology and Oncology, University Medicine Greifswald</name>
      <address>
        <city>Greifswald</city>
        <zip>17475</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Holger Lode, Prof. Dr.</last_name>
      <phone>+49-(0)3834-8622390</phone>
    </contact>
    <investigator>
      <last_name>Hagen Graf Einsiedel, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Reinhard Schneppenheim, Prof. Dr.</last_name>
      <phone>+49-(0)74105-3796</phone>
    </contact>
    <investigator>
      <last_name>Gabriele Escherich, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Pediatric and Adolescent Helth, University Medical Center Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wolfgang Behnisch, Dr.</last_name>
      <phone>+49 (0)6221-564555</phone>
    </contact>
    <investigator>
      <last_name>Wolfgang Behnisch, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinic and Polyclinic of Oncology and Haematology, Herdecke</name>
      <address>
        <city>Herdecke</city>
        <zip>58313</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alfred Längler, Dr. med.</last_name>
      <phone>+49-(0)2330-623893</phone>
    </contact>
    <investigator>
      <last_name>Alfred Längler, Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital Medical Center, Pediatric Haematology and Oncology</name>
      <address>
        <city>Homburg</city>
        <zip>66421</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Norbert Graf, Prof. Dr.</last_name>
      <phone>+49-(0)6841-1628411</phone>
    </contact>
    <investigator>
      <last_name>Norbert Graf, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinic of Pediatric Hematology and Oncology, Kassel</name>
      <address>
        <city>Kassel</city>
        <zip>34125</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michaela Nathrath, Prof.</last_name>
      <phone>+49 (0)561-980-3504</phone>
    </contact>
    <investigator>
      <last_name>Michaela Nathrath, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Pediatrics, University Medicine of Schleswig-Holstein, Campus Kiel</name>
      <address>
        <city>Kiel</city>
        <zip>24105</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gunnar Cario, Dr.</last_name>
      <phone>+49-(0)431-597-1834</phone>
    </contact>
    <investigator>
      <last_name>Gunnar Cario, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinic of Pediatric and Adolescent Helth, Koblenz-Mayen</name>
      <address>
        <city>Koblenz</city>
        <zip>56073</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rudolf Ferrari, Dr.</last_name>
      <phone>+49 (0)261-499- 2602</phone>
    </contact>
    <investigator>
      <last_name>Rudolf Ferrari, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Helios Klinikum Krefeld Department of Paediatric and Adolescent Medicine</name>
      <address>
        <city>Krefeld</city>
        <zip>47805</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Imschweiler, Dr.</last_name>
      <phone>+49-(0)2151-322301</phone>
    </contact>
    <contact_backup>
      <last_name>Tim Niehues, Prof.Dr.</last_name>
      <phone>+49-(0)2151-322301</phone>
    </contact_backup>
    <investigator>
      <last_name>Thomas Imschweiler, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinic of Oncology and Hematology, Johannes Wesling Klinikum</name>
      <address>
        <city>Minden</city>
        <zip>32429</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bernhard Erdlenbruch, Prof. Dr.</last_name>
      <phone>+49-(0)571-790-54001</phone>
    </contact>
    <investigator>
      <last_name>Bernhard Erdlenbruch, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Paediatric Oncology and Hematology, Cnopf`sche Kinderklinik</name>
      <address>
        <city>Neuendettelsau</city>
        <zip>91564</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wolfram Scheurlen, Prof. Dr.</last_name>
      <phone>+49-(0)911-33403000</phone>
    </contact>
    <investigator>
      <last_name>Wolfram Scheurlen, Prof.Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of General Pediatrics, Hematology and Oncology Oldenburg gGmbH</name>
      <address>
        <city>Oldenburg</city>
        <zip>26133</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hermann Müller, Prof. Dr.</last_name>
      <phone>+49-(0)441-403-2013</phone>
    </contact>
    <investigator>
      <last_name>H. Müller, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinic of Paediatric and Adolescend, University Rostock</name>
      <address>
        <city>Rostock</city>
        <zip>18057</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carl-Friedrich Classen, Dr.</last_name>
      <phone>+49-(0)381-4947262</phone>
    </contact>
    <investigator>
      <last_name>Carl-Friedrich Classen, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinic of Paediatric Oncology and Hematology, Helios Klinikum Schwerin</name>
      <address>
        <city>Schwerin</city>
        <zip>19049</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Güttel, Dr.</last_name>
      <phone>+49-(0)385-520-2710</phone>
    </contact>
    <investigator>
      <last_name>Christian Güttel, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinic Trier, Klinikum Mutterhaus der Bromäerinnen</name>
      <address>
        <city>Trier</city>
        <zip>54290</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefan Weis, Dr.</last_name>
      <phone>+49-(0)651-94782593</phone>
    </contact>
    <investigator>
      <last_name>Stefan Weis, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm</name>
      <address>
        <city>Ulm</city>
        <zip>89075</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Klaus-Michael Debatin, Prof. Dr.</last_name>
      <phone>+49-(0)731-50057482</phone>
    </contact>
    <investigator>
      <last_name>Daniel Steinbach, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 6, 2012</study_first_submitted>
  <study_first_submitted_qc>June 12, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 14, 2012</study_first_posted>
  <last_update_submitted>March 4, 2014</last_update_submitted>
  <last_update_submitted_qc>March 4, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 5, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Heinrich-Heine University, Duesseldorf</investigator_affiliation>
    <investigator_full_name>Klinik für Kinder-Onkologie, -Hämatologie und Klinische Immu</investigator_full_name>
    <investigator_title>principal investigator and senior physician university paediatric clinic</investigator_title>
  </responsible_party>
  <keyword>osteonecrosis</keyword>
  <keyword>children</keyword>
  <keyword>pediatric</keyword>
  <keyword>acute lymphoblastic leukaemia</keyword>
  <keyword>lymphoblastic lymphoma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lymphoma</mesh_term>
    <mesh_term>Leukemia</mesh_term>
    <mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
    <mesh_term>Leukemia, Lymphoid</mesh_term>
    <mesh_term>Lymphoma, Non-Hodgkin</mesh_term>
    <mesh_term>Osteonecrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

